A detailed history of Core Alternative Capital transactions in Enovis Corp stock. As of the latest transaction made, Core Alternative Capital holds 10 shares of ENOV stock, worth $453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$453
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$55.44 - $63.8 $7,318 - $8,421
-132 Reduced 92.96%
10 $0
Q4 2023

Feb 14, 2024

SELL
$43.67 - $57.07 $2,620 - $3,424
-60 Reduced 29.7%
142 $7,000
Q2 2023

Jul 27, 2023

BUY
$52.7 - $64.12 $1,317 - $1,603
25 Added 14.12%
202 $12,000
Q1 2023

Apr 18, 2023

SELL
$49.5 - $65.92 $693 - $922
-14 Reduced 7.33%
177 $9,000
Q2 2022

Aug 01, 2022

BUY
$55.0 - $70.47 $10,505 - $13,459
191 New
191 $11,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.45B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.